Cleared Traditional

K151006 - EarlySense Central Display Station (CDS)

K151006 is an FDA 510(k) clearance for EarlySense Central Display Station (CDS), manufactured by Earlysense, Ltd.. The device is a Class 2 Cardiovascular device with product code MSX cleared through the Traditional 510(k) pathway after a 138-day FDA review.

K151006 · Earlysense, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2015
Decision
138d
Days
Class 2
Risk

K151006 is an FDA 510(k) clearance for the EarlySense Central Display Station (CDS). Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Earlysense, Ltd. (Ramat Gan, IL). The FDA issued a Cleared decision on August 31, 2015 after a review of 138 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Earlysense, Ltd. devices

FDA 510(k) Submission Details - K151006

510(k) Number K151006 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2015
Decision Date August 31, 2015
Days to Decision 138 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 125d · This submission: 138d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MSX Device Classification - Class 2, Special Controls

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 74
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K151006.
Athena GTX Device Management Suite (ADMS) Software
K173203 · Athena Gtx · Mar 2018
BeneVision Central Monitoring System
K162607 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Apr 2017
CareEvent inclusive of the CareEvent Mobile Application accessory
K161164 · Philips Medical Systems · Jun 2016
Hypervisor IX Monitoring System
K150632 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jul 2015
CareEvent
K142935 · Philips Medical Systems · Jan 2015
INFINITY EXPLORER SOFTWARE, C700 FOR IT PATIENT VICINITY WORKSTATION
K141756 · Draeger Medical Systems, Inc. · Dec 2014